Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Ganglioglioma
100%
Glioblastoma
72%
Bevacizumab
34%
Temozolomide
30%
Isocitrate Dehydrogenase
26%
Overall Survival
25%
Neoplasm
25%
Molecular Diagnosis
25%
Oligodendroglioma
24%
Magnetic Resonance Imaging
24%
Tumor
22%
Intracranial Tumor
22%
Cerebrospinal Fluid
20%
Radiation Therapy
20%
Promoter Region
19%
Chemotherapy
17%
Diffusion MRI
17%
Gadolinium
16%
Brain Cancer
14%
Nimustine
13%
NMR Spectroscopy
13%
Diagnosis
13%
Elderly Patient
13%
Deterioration
11%
Gene Mutation
11%
Oligoastrocytoma
10%
Vincristine
9%
Procarbazine
9%
Central Nervous System Tumor
8%
Retrospective Study
8%
Genetic Marker
8%
Pediatrics
8%
Meningioma
8%
Chemoradiotherapy
8%
Long-Term Outcome
8%
Liquid Biopsy
7%
High Resolution Melting Analysis
7%
Pilocytic Astrocytoma
7%
Internal Carotid Artery
6%
Isocitrate Dehydrogenase 1
6%
Anterior Cerebral Artery
6%
Hypovolemia
6%
Arteriovenous Fistula
6%
Congenital Malformation
6%
Craniopharyngioma
6%
Medical Care
6%
Cell-Free DNA
6%
Relaxometry
6%
Carotid Endarterectomy
6%
Glioma Cell
6%
Neuroscience
Glioma
74%
Isocitrate Dehydrogenase
34%
Bevacizumab
30%
Oligodendroglioma
28%
Promoter Region
26%
Magnetic Resonance Imaging
25%
Genetics
22%
Astrocytoma
19%
Diffusion MRI
17%
Radiation Therapy
14%
Spectroscopy
13%
Glioblastoma Multiforme
13%
Telomerase Reverse Transcriptase
12%
Isocitrate Dehydrogenase 1
12%
Gene Mutation
9%
Temozolomide
9%
Necrosis
9%
Kinase
6%
Mucin
6%
Procarbazine
6%
Nimustine
6%
Immune Microenvironment
6%
Meningioma
6%
Vincristine
6%
Cyclin-Dependent Kinase
6%
Septum Pellucidum
6%
Intravenous Immunoglobulin
6%
Histone
6%
5' Methylthioadenosine Phosphorylase
6%
Lateral Ventricle
6%
Craniopharyngioma
6%
Cystathionine
6%
Gray Matter
6%
Chemotherapy
6%
Immunohistochemistry
5%
Immunology and Microbiology
Bevacizumab
20%
Cancer Immunotherapy
15%
Macrophage
15%
Programmed Cell Death 1
13%
Chimeric Antigen Receptor
13%
Programmed Death-Ligand 1
13%
Metabolite
12%
Blood Plasma
11%
T Cell
11%
Chimeric Antigen Receptor T-Cell
8%
Syngenic
8%
Transgenic Mouse
7%
CTLA-4
7%
Overall Survival
7%
Epidermal Growth Factor
7%
B Cell
6%
Microglia
6%
Immune Microenvironment
6%
Magnetic Immunoassay
6%
Natural Killer T Cell
6%
Interleukin 10
6%
Tumor Immunity
6%
Preclinical Study
6%
Cell Metabolism
6%
Cell Marker
6%